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Abstract We present a detailed analysis of the oligomeric sub- 
unit organisation of pneumolysin by the use of negative stain 
electron microscopy and image processing to produce a projection 
density map. Analysis of the rotational symmetry has revealed a 
large and variable subunit number, between 40-50. The projected 
subunit density by rotational averaging shows at least two distinct 
subunit domains at different radial positions. Side views of the 
rings reveal further details concerning the dimensions of the oli- 
gomer in the membrane. On the basis of these observations and 
our previous knowledge of the monomer domain structure we 
propose that the 4-domain subunits are packed in a square planar 
arrangement to form the pneumolysin oligomer. 
Key words." Pneumolysin; Pore-forming toxin; 
Electron microscopy; Image processing 
copy. This model consists of a single ring of subunits which 
contains ~30 subunits. The incorporation of pneumolysin oli- 
gomers into liposomes rather than sheep erythrocytes and the 
use of image processing have enabled a more refined analysis 
of the pneumolysin oligomeric structures. Here we present (i) 
a symmetry-averaged projected ensity map of a pneumolysin 
oligomer and (ii) side views of the oligomers. On the basis of 
these images we propose a compact 4-domain subunit model 
for the oligomer. 
2. Materials and methods 
2.1. Pneumolysin expression and purification 
Wildtype pneumolysin protein was expressed in Escherichia coli 
JMI01 and purified as described previously [12]. Sample purity was 
checked by SDS PAGE analysis and haemolytic activity assayed as 
described previously [12]. 
1. Introduction 
Pneumolysin is an important virulence factor of the bacte- 
rium Streptococcus pneumoniae, which is a major pathogen of 
man causing pneumonia, meningitis and otitis media [1]. Pneu- 
molysin belongs to a family of protein toxins, all produced by 
Gram positive bacteria and generally referred to as the thiol- 
activated toxins. These toxins have been shown to have primary 
structural similarities and share a number of biological proper- 
ties [2] including the formation of oligomeric structures in 
cholesterol-containing membranes. 
It has been suggested [3] that cholesterol acts as a membrane 
receptor for these toxins and facilitates the concentration and 
resulting oligomerisation of toxin monomers in the membrane. 
The resulting structures have been reported for many of the 
thiol-activated toxins [4-8]. However the detailed topology of 
these oligomers is still unclear. The subunit structure of perfrin- 
golysin O was studied by electron microscopy [9] and image 
processing which showed an oligomeric structure containing an 
average of 50 subunits, each of which spans the ring and con- 
sists of a periodic repeat of 2.4 nm on the outer rim of the ring. 
A similar analysis was reported for streptolysin O [10] in which 
the authors proposed an oligomeric structure consisting of two 
concentric rings of subunits. 
We have previously proposed [11] an oligomeric model based 
on the dimensions of pneumolysin monomers and oligomers, 
obtained by negative stain and metal-shadow electron micros- 
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2.2. Liposome preparation and incorporation of pneumolysin 
Liposomes were made by dissolving a mixture of phosphati- 
dylcholine (10 pmol), cholesterol (10 /.tmol) and dicetyl phosphate 
(1/.tmol) in chloroform/methanol (1:1, v/v) and drying them under 
nitrogen. The lipids were resuspended in phosphate buffered saline 
(PBS): 8 mM Na2HPO4, 1.5 mM KH2PO4, 0.137 M NaC1, 2.5 mM KCI, 
pH 7.3 and dispersed by sonicating in a sonic water bath for 90 s. The 
suspensions were then filtered through a 0.45 ,um filter (Millipore). 
Equal volumes of pneumolysin (typically ~ 1.0 mg/ml) and liposomes 
were incubated for 30 min prior to electron microscopy. 
2.3. Negative stain electron microscopy 
For negative staining, samples of pneumolysin were vapour fixed for 
1 min over glutaraldehyde solution, prior to rinsing with distilled water 
and contrasting with either 0.8% (w/v) sodium phosphotungstate 
pH 6.8 or unbuffered 2% (w/v) uranyl acetate. All specimens were 
examined and photographed in a Jeol 100CX transmission electron 
microscope fitted with a low dose unit. The magnification was cali- 
brated using a diffraction grating replica. 
2.4. Image processing 
Images of the oligomers were digitised at 6.5A/pixel using a Sentinel 
CCD camera (EEV, Essex) interfaced to a Synergy PC frame store 
(Synoptics Ltd, Cambridge). Analysis of the 2D rotational symmetry 
of the oligomer images was done on a PC with SEMPER software [13]. 
It was possible to centre the rings manually because they are large and 
well defined. Rotational symmetry was determined by calculating the 
rotational utocorrelation function for each ring. The appropriate sym- 
metry was applied to yield symmetry-averaged en views. 
3. Results 
3.1. Face view symmetry 
Pneumolysin incorporates into cholesterol-containing li- 
posomes to form ring-shaped oligomeric structures (Fig. 1), 
which have the same dimensions as those formed in erythrocyte 
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Fig. 1. Electron micrograph of negatively stained pneumolysin oligo- 
mers incorporated into a liposome. Magnification × 170,000. 
membranes [11,14]. Although the majority of these structures 
are incorporated into liposomes, many are also found attached 
directly to the grid. These have the same dimensions as mem- 
brane-incorporated oligomers. Intact rings were used for image 
processing and not the arc-shaped structures which are also 
present. Analysis of the rotational symmetry of the oligomers, 
by rotational autocorrelation (Fig. 2), reveals a large and vari- 
able subunit number of between 40-50. The outer diameter of 
the structures varies according to the number of subunits pres- 
ent in a particular ring (from ~ 3545 nm) and the ring width was 
Correlation 
6.5 ( + 0.5) nm. Rotational averaging of the negatively stained 
rings was used to produce projected ensity maps of pneumoly- 
sin oligomers. In Fig. 3 the density map of a 41-fold ring is 
shown with density contours uperimposed. The structure ap- 
pears as two concentric rings of protein density, separated by 
a gap of lower protein density (darker staining). One subunit 
is outlined in Fig. 3. On symmetry grounds (in order that all 
subunits make equivalent interactions with their neighbours) 
the projected subunit density must consist of an inner and an 
outer radial domain. The region of low protein density appears 
to contain a bridge between the inner and outer radial domains. 
The inner domains are more compact in projection. 
3.2. Side view subunit structure 
The incubation of high concentrations (~10 mg/ml) of pneu- 
molysin in the presence of liposomes for long periods (up to 
8 weeks) caused the oligomeric structures described above to 
form stacks (see Fig. 4). The oligomers appear to stack into 
cylinders which lie on their sides on the grid, providing an 
excellent opportunity to view the side projection of the oli- 
gomer. The resulting side views of the stacks are slightly wider 
in overall diameter than the face views, as would be expected 
in a negatively stained preparation, due to the dehydration- 
induced flattening of the structure onto the grid. The diameter 
of the stacks is-45 nm and the axial translation between individ- 
ual oligomers in the stack is - 10 nm. The inner and outer radial 
domains can be seen in the side projections and their combined 
width is ~8 nm. The inner domain, which lines the pore, has a 
sharper profile. The arrangement of stacked oligomers appears 
helical in some areas with diagonal regions of protein density, 
although orizontally separated layers are also seen (indicated 
in Fig. 4). 
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Fig. 2. Negative stain images and their corresponding rotational self-correlation's, showing 41 and 42 peaks, respectively. 
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Fig. 3. One quadrant of the 41-fold ring shown in Fig. 2, after rotational veraging. The projected ensity map shows the subunit structure of the 
pneumolysin oligomer, with density contours uperposed on the light, stain-excluding protein regions. The repeating subunit motif (shown boxed) 
contains a compact, inner domain, tenuously connected to an elongated outer domain, extending radially outwards. 
4. Discussion 
We have previously reported [11,14] that water-soluble mon- 
omeric pneumolysin i corporates into erythrocyte membranes 
to form large oligomeric ring and arc structures, as reported for 
many other of the membrane-damaging thiol-activated toxins 
[4-8]. The precise mechanism of oligomer formation is cur- 
rently unclear and consequently a detailed knowledge of the 
subunit structure of the oligomer may provide further clues. We 
have extended our preliminary studies (in which we used eryth- 
rocyte membranes for oligomer incorporation) by introducing 
a system of cholesterol-containing liposomes. This system is 
free of contaminating proteins, which increases the sensitivity 
and reproducibility of our experiments. We have shown that 
pneumolysin will incorporate into liposomes to produce oli- 
gomers (Fig. 1) equivalent in appearance and size distribution 
to those found in cell membranes. Negative stain electron mi- 
croscopy and rotational averaging (Fig. 2) were used to get 
projected ensity maps of the individual rings (Fig. 3). 
The rotationally averaged image clearly shows two domains 
of subunit density, with the more elongated omain extending 
radially outwards from the ring. The compact inner domains 
appear to make the ring-forming contacts and line the pore. 
Rotational correlation analysis reveals a large and variable 
subunit number of between 40-50. Previous analysis of pneu- 
molysin monomers [11] by electron microscopy has shown that 
pneumolysin has a four domain structure and this information 
was included in our previous working model for the oligomeric 
structure. Our previous model estimated a subunit number of 
30 and proposed a more extended conformation for the subunit 
domains. 
The side-view images of the oligomers have enabled us to 
refine our previous model. Images of stacked pneumolysin oli- 
gomers (Fig. 4) provide an estimate of the height (based on their 
axial translation i  the stacks) of the oligomers (~ 10 nm). This 
value is in good agreement with our previous estimate (~9 nm) 
obtained using metal-shadowing methods [11]. As far as we 
know these stacks have not been detected with other thiol- 
activated toxins. A slightly larger diameter was measured for 
the oligomers in the stacks, due to the flattening of the structure 
on the grid during the negative stain process. Unfortunately the 
stacks were not regular enough to produce diffraction spots 
(unpublished results) and so further analysis of the data was not 
possible. This observation was not surprising bearing in mind 
the variable subunit number (40-50). In fact there is some 
evidence of a helical arrangement in the stacks (see Fig. 4) 
although this appears irregular. 
The subunit size and organisation observed for the pneumo- 
lysin oligomer is very similar to that determined for perfringol- 
ysin O [9] and streptolysin O [10]. Previous studies have shown 
that the amino acid sequence of pneumolysin has approxi- 
mately 48% homology with that of perfringolysin O. They have 
been shown to possess imilar biological properties and the ring 
and arc structures at low resolution appear to have similar 
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Fig. 4. A composite of electron micrographs showing negatively stained 
stacks of pneumolysin oligomers. The axial translation ofan individual 
oligomer in the stack is indicated in the higher magnification image (c). 
Arrows show horizontal and diagonal regions of protein density, the 
latter suggesting a helical arrangement. Magnifications: (a),(b) 
x 145,000 and (c) x330,000. 
dimensions. It is likely that the family of thiol-activated toxins 
will have a conserved 3D structure. 
On the basis of the images of pneumolysin oligomers pre- 
sented here, together with our previous knowledge of the mon- 
omer domain structure [11] we propose that each subunit has 
four domains packed in a square planar arrangement, although 
the domain connectivity is not yet clear. We now intend to use 
cryo-EM and image processing to obtain more accurate infor- 
mation on the pneumolysin oligomers. We hope this will even- 
tually enable a 3D reconstruction of the oligomeric structure, 
which in turn will help define the precise mechanism of mem- 
brane damage by these toxins. 
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